News

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

This week we're talking with Dr. Sanjaya Gupta, cardiologist at Saint Luke’s Mid America Heart Institute, about the latest treatment options for this underdiagnosed heart condition.

Dr. Sanjaya Gupta spoke to KSHB about pulsed field ablation, as well as the second Saint Luke's patient to undergo this innovative new procedure to treat AFib.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

MedCity News talked to Dr. Sanjaya Gupta, cardiologist at Saint Luke's Mid America Heart Institue, about how the new virtual program to help patients with atrial fibrillation came to be.

The new, co-developed a-fib program delivers holistic care that magnifies specialty providers’ ability to see more patients and improve their quality of life.

During Heart Month, we are talking about atrial fibrillation, the recent changes in guidelines, and how Saint Luke’s is leading the way in innovative treatments for those who have a-fib.

Saint Luke’s Mid America Heart Institute was the first in Kansas and Missouri, and one of only 27 US institutions, to participate in PULSED AF clinical trial.

In the past, many women born with a heart condition were told they would not be able to birth children safely.